We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

By LabMedica International staff writers
Posted on 01 Oct 2024

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. More...

Antigen-based tests provide quicker results but often lack the sensitivity and accuracy of PCR. Now, a new method that combines confocal fluorescence microscopy with microfluidic laminar flow marks a significant advancement in virus detection. Unlike traditional PCR, this innovative approach can rapidly detect individual virus particles cost-effectively, using a 3D-printed microscopy technology called Brick-MIC. This method boosts both sensitivity and specificity in virus detection, potentially transforming how viral outbreaks are monitored and managed. Its portable and user-friendly design makes it well-suited for wider clinical applications, strengthening public health responses to emerging viral challenges.

The breakthrough virus detection method developed by a group of researchers that included scientists from The Hebrew University of Jerusalem (Rehovot, Israel) uses laminar flow in a microfluidic channel along with fluorescence signals from free dyes and labeled antibodies to reveal key characteristics of nanoparticles. The team demonstrated the method's accuracy by testing it on fluorescent beads and various viruses, including the SARS-CoV-2 Spike protein. One of the key elements of this new assay is the use of hydrodynamic focusing, which significantly enhances sensitivity, enabling virus detection at clinically relevant concentrations.

Its portability and the use of the affordable 3D-printed Brick-MIC setup make it accessible for clinical environments. This innovation signals a shift toward rapid and precise virus detection, in line with personalized healthcare principles. By enabling fast, specific identification of viruses, this technology could help tailor medical interventions to individual patient needs, improving the timeliness and effectiveness of treatments. The research was published in iScience, with the 3D-printed microscopy approach detailed in Science Advances.


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
C-Reactive Protein Rapid Test
Afinion CRP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.